Getting clinical practice guidelines right is crucial for India to control the pandemic

Equally, getting them wrong could lead to damaging consequences.

Jammi Nagaraj Rao

 & 

Dinesh Thakur

· May 30, 2021 · 09:00 am

Which public authority should be in charge of India’s policy on diagnostic kits for Covid-19?

It is important for the Central government to clearly delineate responsibilities as per the constitutional framework.

Dinesh Thakur

 & 

Prashant Reddy T

· Apr 03, 2020 · 07:30 am

Why the Indian Supreme Court’s judgment on combination drugs sends wrong signals

It indicates to High Courts that judges can sidestep the legislative procedures on complex regulatory issues if these are deemed inconvenient.

Dinesh Thakur

 & 

Prashant Reddy T

· Dec 29, 2017 · 02:30 pm

A new class of drugs is here – but India is dangerously inept at dealing with them

There is serious doubt over the competence of India’s regulatory regime for biosimilar drugs. If this isn't fixed soon, the biggest losers will be Indian patients.

Dinesh Thakur

· Sep 16, 2015 · 09:00 am